+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Use of economic predictions to make formulary decisions

Use of economic predictions to make formulary decisions

American Journal of Health-System Pharmacy 76(Suppl._1): S15-S20

The accuracy of cost savings and reimbursement predictions for medications added to an academic medical center formulary was assessed. Formulary changes over a 5-year period were reviewed by the investigators. Medications were included if the medication was added to formulary and the monograph included cost savings or reimbursement data that indicated a positive net margin. The primary endpoints were percent predicted cost savings and net margin per medication based on medication cost only. Secondary endpoints included the percent of medications with at least 100% predicted cost savings or net margin and evaluation of median percent predicted savings or net margin individually. The pharmacy and therapeutics committee reviewed 558 formulary agenda items, 184 of which were selected for further analysis. In total, 19 medications were identified as having a predicted monetary advantage. The endpoints of percent predicted cost savings and net margin yielded a median of 76.5% (range 72.9-188.71%) (n = 3) and 148.2% (IQR 108.9-543.3%) (n = 16), respectively. For 13 (68%) of 19 medications, the percent predicted cost savings or net margin was at least 100%. Economic predictions utilized for formulary management at an academic medical center generated net positive monetary value for medications where predicted cost savings or reimbursement factored into the decision to add a medication to the formulary.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 066486719

Download citation: RISBibTeXText

PMID: 30753317

DOI: 10.1093/ajhp/zxy024

Related references

Using economic evaluations to make formulary coverage decisions. So much for guidelines. Pharmacoeconomics 18(1): 55-62, 2000

Use of economic models in formulary decisions. Expert Review of Pharmacoeconomics and Outcomes Research 2(4): 295-298, 2002

Using Outcome Predictions to Make Treatment Decisions. Chest Journal 91(4): 475-477, 1987

The Arrival of Economic Evidence in Managed Care Formulary Decisions. Medical Care 43(Suppl.): Ii-27-Ii-32, 2005

Application of economic analyses in U.S. managed care formulary decisions: a private payer's experience. Journal of Managed Care Pharmacy 12(9): 726-735, 2007

The arrival of economic evidence in managed care formulary decisions: the unsolicited request process. Medical Care 43(7 Suppl.): 27-32, 2005

Incorporating clinical outcomes and economic consequences into drug formulary decisions: a practical approach. American Journal of Managed Care 5(3): 277-285, 1999

Using outcome predictions to make treatment decisions. Simple, logical, and unexpectedly problematic. Chest 91(4): 475-477, 1987

Neuroeconomics: Using Neuroscience to Make Economic Predictions. Economic journal: the journal of the British Economic Association 117(519): C26-C42, 2007

Consumers make economic decisions. 1990

Supplement: Cost-Effectiveness Analysis in US Healthcare Decision-Making Where Is It Going? || The Arrival of Economic Evidence in Managed Care Formulary Decisions: The Unsolicited Request Process. Medical Care 43(7): Ii27-Ii32, 2005

Willingness to make health decisions associated with socio-economic factors. Hospital Management Quarterly 4-6, 20, 1985

Using surveillance and economic data to make informed decisions about rotavirus vaccine introduction. Vaccine 36(51): 7755-7758, 2018

Critical reviews of economic analyses in order to make health care decisions for cancer. Annals of Oncology 9(11): 1167-1172, 1998

Behavioral economics and decision making: Applying insights from psychology to understand how people make economic decisions. Journal of Economic Psychology 29(5): 613-618, 2008